Back
CRISPR Therapeutics AG Stock Price Chart
Buy
66
CRSP
CRISPR Therapeutics AG
Last Price:
56.19
Seasonality Move:
18.28%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is relatively stagnant and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.78 | Buy |
| 20-day SMA: | 54.94 | Buy |
| 50-day SMA: | 62.33 | Sell |
| 200-day SMA: | 59.32 | Sell |
| 8-day EMA: | 55.47 | Buy |
| 20-day EMA: | 56.17 | Buy |
| 50-day EMA: | 60.58 | Sell |
| 200-day EMA: | 61.45 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.69 | Sell |
| Relative Strength Index (14 RSI): | 47.02 | Sell |
| Chaikin Money Flow: | 885602 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.68 - 56.9) | Buy |
| Bollinger Bands (100): | (56.93 - 76.01) | Sell |
CRISPR Therapeutics AG Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 56.22 while CRSP 8-day simple moving average is 54.78, which is a Buy signal.
- The stock price of CRSP is 56.22 while CRISPR Therapeutics AG 20-day SMA is 54.94, which makes it a Buy.
- CRISPR Therapeutics AG 50-day simple moving average is 62.33 while CRSP share price is 56.22, making it a Sell technically.
- CRSP stock price is 56.22 and CRISPR Therapeutics AG 200-day simple moving average is 59.32, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Buy
66
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a Buy
The current CRISPR Therapeutics AG [CRSP] share price is $56.22. The Score for CRSP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
4.77B
Price in USD:
56.22
Share Volume:
1.07M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
37.55
Buy
66
CRISPR Therapeutics AG (CRSP)
is a Buy
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?
The CRISPR Therapeutics AG stock price is 56.22 USD today. -
Will CRSP stock go up or go down?
CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators -
Is CRISPR Therapeutics AG overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is not overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
- CRISPR Therapeutics AG share price is 56.22 while CRSP 8-day exponential moving average is 55.47, which is a Buy signal.
- The stock price of CRSP is 56.22 while CRISPR Therapeutics AG 20-day EMA is 56.17, which makes it a Buy.
- CRISPR Therapeutics AG 50-day exponential moving average is 60.58 while CRSP share price is 56.22, making it a Sell technically.
- CRSP stock price is 56.22 and CRISPR Therapeutics AG 200-day simple moving average is 61.45, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
- Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.03 per share, a decrease this year of $2.50 per share, and an increase next year of $1.15 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
- CRSP Moving Average Covergence Divergence (MACD) indicator is -1.69, suggesting CRISPR Therapeutics AG is a Sell
- CRISPR Therapeutics AG Relative Strength Index (RSI) is 47.02, which suggest CRISPR Therapeutics AG is oversold
- The Bollinger Bands (25) for CRISPR Therapeutics AG is (53.68 - 56.9), which suggest CRISPR Therapeutics AG is a Sell
- The Bollinger Bands (100) for CRISPR Therapeutics AG is (56.93 - 76.01), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.